Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BALAXI PHARMA vs SYMBIOX INVESTMENT - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BALAXI PHARMA SYMBIOX INVESTMENT BALAXI PHARMA/
SYMBIOX INVESTMENT
 
P/E (TTM) x 12.3 39.7 31.0% View Chart
P/BV x 2.2 0.4 592.2% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 BALAXI PHARMA   SYMBIOX INVESTMENT
EQUITY SHARE DATA
    BALAXI PHARMA
Mar-24
SYMBIOX INVESTMENT
Mar-24
BALAXI PHARMA/
SYMBIOX INVESTMENT
5-Yr Chart
Click to enlarge
High Rs6865 13,892.7%   
Low Rs4003 15,684.3%   
Sales per share (Unadj.) Rs221.41.2 17,769.8%  
Earnings per share (Unadj.) Rs-2.20.1 -3,294.3%  
Cash flow per share (Unadj.) Rs-0.30.1 -395.1%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs181.310.1 1,798.8%  
Shares outstanding (eoy) m10.9031.29 34.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.53.0 81.6%   
Avg P/E ratio x-248.056.3 -440.7%  
P/CF ratio (eoy) x-2,051.655.7 -3,681.4%  
Price / Book Value ratio x3.00.4 806.1%  
Dividend payout %00-   
Avg Mkt Cap Rs m5,919117 5,051.5%   
No. of employees `000NANA-   
Total wages/salary Rs m2802 15,575.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m2,41339 6,190.2%  
Other income Rs m62 275.2%   
Total revenues Rs m2,41941 5,860.6%   
Gross profit Rs m620 31,235.0%  
Depreciation Rs m210 104,900.0%   
Interest Rs m280 276,600.0%   
Profit before tax Rs m202 812.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m440 11,287.2%   
Profit after tax Rs m-242 -1,147.6%  
Gross profit margin %2.60.5 496.7%  
Effective tax rate %218.515.8 1,380.1%   
Net profit margin %-1.05.3 -18.5%  
BALANCE SHEET DATA
Current assets Rs m2,102319 659.4%   
Current liabilities Rs m5424 15,013.0%   
Net working cap to sales %64.6808.5 8.0%  
Current ratio x3.988.3 4.4%  
Inventory Days Days8925 0.8%  
Debtors Days Days84314,392 5.9%  
Net fixed assets Rs m4820 267,616.7%   
Share capital Rs m109313 34.8%   
"Free" reserves Rs m1,8672 76,201.2%   
Net worth Rs m1,976315 626.6%   
Long term debt Rs m00-   
Total assets Rs m2,583319 810.0%  
Interest coverage x1.7248.0 0.7%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.1 764.2%   
Return on assets %0.10.7 22.4%  
Return on equity %-1.20.7 -182.9%  
Return on capital %2.40.8 307.4%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m6480-   
Fx outflow Rs m190-   
Net fx Rs m6290-   
CASH FLOW
From Operations Rs m49-31 -159.0%  
From Investments Rs m-1028 -37.0%  
From Financial Activity Rs m303NA-  
Net Cashflow Rs m341-2 -14,814.8%  

Share Holding

Indian Promoters % 66.0 3.3 1,981.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 16.5 0.0 -  
FIIs % 16.5 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 34.0 96.7 35.2%  
Shareholders   7,863 24,079 32.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BALAXI PHARMA With:   ADANI ENTERPRISES    REDINGTON    MMTC    SIRCA PAINTS INDIA    MSTC    


More on BALAXI PHARMA vs SYMBIOX INVESTMENT

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BALAXI PHARMA vs SYMBIOX INVESTMENT Share Price Performance

Period BALAXI PHARMA SYMBIOX INVESTMENT S&P BSE HEALTHCARE
1-Day 2.35% -4.80% 0.96%
1-Month -9.86% 16.36% 1.28%
1-Year -81.85% 28.23% 46.29%
3-Year CAGR -49.68% 34.20% 19.65%
5-Year CAGR -33.77% 72.06% 26.13%

* Compound Annual Growth Rate

Here are more details on the BALAXI PHARMA share price and the SYMBIOX INVESTMENT share price.

Moving on to shareholding structures...

The promoters of BALAXI PHARMA hold a 66.0% stake in the company. In case of SYMBIOX INVESTMENT the stake stands at 3.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BALAXI PHARMA and the shareholding pattern of SYMBIOX INVESTMENT.

Finally, a word on dividends...

In the most recent financial year, BALAXI PHARMA paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

SYMBIOX INVESTMENT paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of BALAXI PHARMA, and the dividend history of SYMBIOX INVESTMENT.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Zooms Over 1,200 Points | Nifty Above 24,300 | Adani Ports Climbs 4% Sensex Today Zooms Over 1,200 Points | Nifty Above 24,300 | Adani Ports Climbs 4%(10:30 am)

Asian stocks experienced a notable rally alongside US equity futures on Monday, marking a positive turn for the markets. The dollar retreated against other currencies as bond yields declined.